SARS-CoV-2 Causes Brain Damage: Therapeutic Intervention with AZD8797
Description
Elevated CX3CL1 is associated with severe COVID-19 and neurologic symptoms. We aimed to investigate the potential protective effects of selective CX3CR1 antagonist AZD8797 on SARS-CoV-2-induced neuronal damage, and to identify the underlying
